Advertisement
Screener

CUBIST PHARMACEUTICALS INC Amortization of Intangible Assets

CUBIST PHARMACEUTICALS INC Amortization of Intangible Assets

CUBIST PHARMACEUTICALS INC reported Amortization of Intangible Assets of $28.00 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2014-11-07

  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for the quarter ending 2014-09-30 was $28.00M, a 438.46% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for the quarter ending 2014-06-30 was $17.50M, a 236.54% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for the quarter ending 2014-03-31 was $16.20M, a 217.65% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for the quarter ending 2013-12-31 was $13.40M, a 157.69% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for fiscal 2013 was $28.80M, a 37.80% increase from fiscal 2012.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for fiscal 2012 was $20.90M, a 497.14% increase from fiscal 2011.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for fiscal 2011 was $3.50M, a 20.69% increase from fiscal 2010.
  • CUBIST PHARMACEUTICALS INC amortization of intangible assets for fiscal 2010 was $2.90M.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 month
2014-09-30$28.00M
10-Q · filed 2014-11-07
$45.50M
derived: sum of 2 quarters · filed 2014-11-07
$61.70M
10-Q · filed 2014-11-07
$75.10M
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30$17.50M
10-Q · filed 2014-08-11
$33.70M
10-Q · filed 2014-08-11
$47.10M
derived: sum of 3 quarters · filed 2014-08-11
$52.30M
derived: sum of 4 quarters · filed 2014-11-07
2014-03-31$16.20M
10-Q · filed 2014-05-02
$29.60M
derived: sum of 2 quarters · filed 2014-05-02
$34.80M
derived: sum of 3 quarters · filed 2014-11-07
$40.00M
derived: sum of 4 quarters · filed 2014-11-07
2013-12-31$13.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$18.60M
derived: sum of 2 quarters · filed 2014-11-07
$23.80M
derived: sum of 3 quarters · filed 2014-11-07
$28.80M
10-K · filed 2014-02-25
2013-09-30$5.20M
10-Q · filed 2014-11-07
$10.40M
derived: sum of 2 quarters · filed 2014-11-07
$15.40M
10-Q · filed 2014-11-07
$20.70M
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30$5.20M
10-Q · filed 2014-08-11
$10.20M
10-Q · filed 2014-08-11
$15.50M
derived: sum of 3 quarters · filed 2014-08-11
$20.70M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$5.10M
10-Q · filed 2014-05-02
$10.30M
derived: sum of 2 quarters · filed 2014-05-02
$15.50M
derived: sum of 3 quarters · filed 2014-05-02
$20.70M
derived: sum of 4 quarters · filed 2014-05-02
2012-12-31$5.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$10.40M
derived: sum of 2 quarters · filed 2014-02-25
$15.60M
derived: sum of 3 quarters · filed 2014-02-25
$20.90M
10-K · filed 2014-02-25
2012-09-30$5.20M
10-Q · filed 2013-11-12
$10.40M
derived: sum of 2 quarters · filed 2013-11-12
$15.70M
10-Q · filed 2013-11-12
$17.20M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$5.20M
10-Q · filed 2013-08-06
$10.40M
10-Q · filed 2013-08-06
$12.00M
derived: sum of 3 quarters · filed 2014-02-25
$12.60M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$5.20M
10-Q · filed 2013-05-07
$6.80M
derived: sum of 2 quarters · filed 2014-02-25
$7.40M
derived: sum of 3 quarters · filed 2014-02-25
2011-12-31$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$2.20M
derived: sum of 2 quarters · filed 2014-02-25
$3.50M
10-K · filed 2014-02-25
2011-09-30$600.00K
10-Q · filed 2012-11-05
$1.90M
10-Q · filed 2012-11-05
2010-12-31$2.90M
10-K · filed 2013-02-27